Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-005182
Filing Date
2025-11-14
Accepted
2025-11-14 20:00:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9660
  Complete submission text file 0001172661-25-005182.txt   11631
Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

EIN.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 135 W 41ST ST, FLOOR 5 NEW YORK NY 10036
Business Address 135 W 41ST ST, FLOOR 5 NEW YORK NY 10036 646-790-5756
INTELLIGENT BIO SOLUTIONS INC. (Subject) CIK: 0001725430 (see all company filings)

EIN.: 821512711 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94012 | Film No.: 251488987
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)